Showing results (461-470 of 638) with videos related to
Sort By:
Pageof 64
Social Science & Medicine (1982)|September 13, 2023
Solitary confinement and the well-being of people in prisonKevin A Wright, Jacob T N Young, Caitlin G Matekel, et al.BMC Infectious Diseases|April 22, 2017
Identifying and characterizing hepatitis C virus hotspots in Massachusetts: a spatial epidemiological approachThomas J Stopka, Michael A Goulart, David J Meyers, et al.Case Reports in Psychiatry|April 11, 2023
A Manualized Behavioral Therapy Intervention for Youth with Autism Spectrum Disorder and Substance Use DisorderJames McKowen, Amy Berger, Joshua Towbin, et al.Plos Neglected Tropical Diseases|January 9, 2018
Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis modelErin Stebbins, Rajiv S Jumani, Connor Klopfer, et al.Molecules (Basel, Switzerland)|March 6, 2021
Tuning π-Acceptor/σ-Donor Ratio of the 2-Isocyanoazulene Ligand: Non-Fluorinated Rival of Pentafluorophenyl Isocyanide and Trifluorovinyl Isocyanide DiscoveredMason D Hart, John J Meyers, Zachary A Wood, et al.JAMA Network Open|July 13, 2019
Perspectives of Medicare Advantage Plan Representatives on Addressing Social Determinants of Health in Response to the CHRONIC Care ActKali S Thomas, Shayla N M Durfey, Emily A Gadbois, et al.ACS Omega|November 1, 2021
Mechanism of Action of N-Acyl and N-Alkoxy Fosmidomycin Analogs: Mono- and Bisubstrate Inhibition of IspC from Plasmodium falciparum, a Causative Agent of MalariaMisgina B Girma, Haley S Ball, Xu Wang, et al.Nature Chemical Biology|March 27, 2012
Rapid and orthogonal logic gating with a gibberellin-induced dimerization systemTakafumi Miyamoto, Robert DeRose, Allison Suarez, et al.The Journal of Urology|July 1, 1992
Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group studyF J Meyers, B Blumenstein, E D Crawford, et al.Investigational New Drugs|July 30, 1999
Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124)F J Meyers, D Lew, P N Lara, et al.Pageof 64